BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34774515)

  • 21. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refinement of breast cancer molecular classification by miRNA expression profiles.
    Søkilde R; Persson H; Ehinger A; Pirona AC; Fernö M; Hegardt C; Larsson C; Loman N; Malmberg M; Rydén L; Saal L; Borg Å; Vallon-Christerson J; Rovira C
    BMC Genomics; 2019 Jun; 20(1):503. PubMed ID: 31208318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
    Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
    Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
    BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Distributed Classifier for MicroRNA Target Prediction with Validation Through TCGA Expression Data.
    Ghoshal A; Zhang J; Roth MA; Xia KM; Grama AY; Chaterji S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(4):1037-1051. PubMed ID: 29993641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
    Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
    Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.
    Baffa R; Fassan M; Volinia S; O'Hara B; Liu CG; Palazzo JP; Gardiman M; Rugge M; Gomella LG; Croce CM; Rosenberg A
    J Pathol; 2009 Oct; 219(2):214-21. PubMed ID: 19593777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
    Volinia S; Croce CM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
    Kelly H; Downing T; Tuite NL; Smith TJ; Kerin MJ; Dwyer RM; Clancy E; Barry T; Reddington K
    PLoS One; 2015; 10(9):e0137389. PubMed ID: 26355751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA expression profiling of male breast cancer.
    Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A
    Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.
    Wyman SK; Parkin RK; Mitchell PS; Fritz BR; O'Briant K; Godwin AK; Urban N; Drescher CW; Knudsen BS; Tewari M
    PLoS One; 2009; 4(4):e5311. PubMed ID: 19390579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.
    Wu X; Zeng R; Wu S; Zhong J; Yang L; Xu J
    Gene; 2015 Feb; 557(2):195-200. PubMed ID: 25523096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.